The proposed bill aims to enhance access to 340B drugs by prohibiting manufacturers and wholesale distributors from restricting or interfering with the delivery or distribution of these drugs to pharmacies that are under contract with 340B covered entities. The bill introduces new legal language under Minnesota Statutes, chapter 62J, specifically section 62J.96, which outlines that manufacturers and distributors cannot limit pharmacy access to 340B drugs unless such actions are prohibited under the 340B Drug Pricing Program. Additionally, the bill provides definitions for key terms such as "manufacturer," "340B covered entity," and "wholesale distributor."

Furthermore, the bill amends Minnesota Statutes 2023 Supplement, section 151.071, subdivision 2, to include a new provision that establishes a violation for manufacturers or wholesale distributors who contravene the newly inserted section 62J.96. This addition emphasizes the importance of compliance with the regulations surrounding 340B drugs and aims to protect pharmacies' ability to dispense these medications effectively. The bill reflects a commitment to ensuring that patients have access to affordable medications through the 340B program.